Hot Investor Mandate: USA-Based Private Investment Firm Invests Up to $50M in Both Public & Private Companies with High Impact Investment Angle

20 Aug

A private investment partnership based in the USA is dedicated to providing impact investment capital to life science and healthcare companies in both public and private markets. The firm can invest from $1 – 50M depending on the stage of development of the company. The firm is open to global opportunities and has expertise with working in global markets.

The firm is most interested in therapeutics opportunities, and medical devices to a lesser extent. The firm looks for technologies that have the potential to make a significant impact to the global population. In therapeutics, the firm can look as early as pre-clinical to Phase I/IIa. For devices, the firm looks for those that are close to 510k FDA approval.

The firm invests in both publicly traded and privately owned companies. The firm prefers to work with experienced, transparent management teams with clearly demonstrated growth and defined (or capable of helping define) exit strategy. The firm prefers to lead and requires a board of directors seat.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: